Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy

Long-term uninterrupted therapy is essential for maximizing clinical benefits of antiangiogenic drugs (AADs) in cancer patients. Unfortunately, nearly all clinically available AADs are delivered to cancer patients using disrupted regimens. We aim to develop lifetime, nontoxic, effective, orally acti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Proc Natl Acad Sci U S A
Main Authors: Zhang, Yin, Sun, Meili, Huang, Guichun, Yin, Linlin, Lai, Qinghua, Yang, Yunlong, Xing, Xiaoming, Yu, Guohua, Sun, Yuping, Wang, Xinsheng, Nie, Guohui, Liu, Yizhi, Cao, Yihai
Formato: Artigo
Idioma:Inglês
Publicado: National Academy of Sciences 2017
Assuntos:
PNAS Plus
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5495268/
https://ncbi.nlm.nih.gov/pubmed/28607065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1705066114
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares